What was the main purpose of this 8-K filing?

The main purpose of this 8-K filing was to report the official results of the votes cast by Merck's shareholders at the Annual Meeting held on May 24, 2011. This includes the outcomes of director elections, auditor ratification, and advisory votes on executive compensation.

Were there any concerns raised by shareholders regarding director re-elections?

While all nominated directors were re-elected, the voting results show varying levels of support. Most directors received overwhelming 'For' votes, but a few, such as Rochelle B. Lazarus and Craig B. Thompson, saw a higher number of 'Against' votes and abstentions compared to others, suggesting potential areas for continued board oversight and communication.

What is the implication of the vote on the frequency of executive compensation advisory votes?

The majority vote in favor of a 'ONE year' frequency means that shareholders want Merck to hold an advisory vote on executive compensation annually. This indicates a preference for more frequent direct shareholder input on executive pay.

How should investors interpret the 'Broker Non-Votes'?

Broker non-votes occur when a broker holding shares in "street name" does not receive voting instructions from the beneficial owner for a proposal where the broker does not have discretionary voting power. For these proposals, broker non-votes do not count towards the total votes cast, but they can influence whether a proposal reaches the required threshold for approval if the vote is very close. In this filing, they represent shares held by brokers that were not voted on specific matters.

MRK 8-K: Shareholder Matters

Summary

This Form 8-K filed by Merck & Co., Inc. on May 27, 2011, reports the results of its Annual Meeting of Shareholders held on May 24, 2011. The primary focus of the filing is the voting outcomes on several key proposals, including the election of directors, ratification of its independent auditor, and advisory votes on executive compensation and the frequency of future executive compensation votes. Investors should note the overwhelming support for the re-election of all nominated directors and the ratification of PricewaterhouseCoopers LLP as the independent auditor. While the advisory vote on executive compensation received a strong majority in favor, a significant number of shareholders opted for a one-year frequency for future advisory votes on executive compensation, indicating a potential area of continued engagement between management and shareholders on this matter.

Key Highlights

1All nominated directors were re-elected at the Annual Meeting of Shareholders.
2PricewaterhouseCoopers LLP was ratified as the Company's independent registered public accounting firm for 2011 with strong shareholder support.
3The advisory vote to approve executive compensation of Named Executive Officers received majority support, though with a notable number of dissenting votes and abstentions.
4Shareholders voted to hold advisory votes on executive compensation on an annual basis (for ONE year) by a significant margin.
5The filing details the 'For', 'Against', 'Abstained', and 'Broker Non-Votes' for each director nominee and proposal, providing transparency on shareholder sentiment.
6A substantial number of broker non-votes were recorded across most proposals, which is typical for annual meetings where certain proposals may not require broker discretionary voting.

Merck & Co., Inc. 8-K Report, Shareholder Vote Results (May 27, 2011)

Summary

Key Highlights

Frequently Asked Questions